Stanabol Tablets – British Dragon Pharmaceuticals
Active Substance | Stanozolol |
Dosage Form | Oral tablets, 10 mg per tablet |
Half-life | Approximately 9 hours |
Hepatotoxicity | Moderate |
Anabolic Cycle | Cutting |
Water Retention | No |
Aromatization | No |
Brand Name | British Dragon Pharmaceuticals |
Country of Origin | Not specified |
Indications | Originally developed to treat hereditary angioedema; commonly used off-label for muscle mass and strength enhancement |
Contraindications | Prostate cancer, male breast cancer, severe cardiac, hepatic, or renal disease, hypersensitivity to Stanozolol |
Side Effects | Acne, hair loss, increased aggression, joint pain, potential cardiovascular issues |
Administration Route | Oral |
Legal Status | Prescription only; banned in competitive sports by most athletic organizations |
Detection Time | Up to 2 months |
Cairin –
Good quality pills. Quite fast delivery.